| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0009 |